Strain Profile
Save

Bifidobacterium longum SP 07/3

◔ Human-origin
Sequenced
Public genome assembly available

Bifidobacterium longum SP 07/3 has been studied primarily as one component of a multi-strain combination, alongside Lactobacillus gasseri PA 16/8 and Bifidobacterium bifidum M 20/5. A double-blind randomized controlled trial examined this combination in relation to the duration and severity of common cold episodes compared to placebo, and a European regulatory review assessed a related immune-support claim as having limited substantiation under strict clinical criteria. In vitro work has examined immune signaling pathway activation in cell culture, though isolating this strain's individual contribution from the multi-strain blend is difficult. Strain-specific evidence for B. longum SP 07/3 alone remains limited. These are research topics, not findings; the papers do not establish that this strain treats or prevents any condition.

Where it's been studied

Share of this strain's 10 body-system-tagged papers that concern each system. Research coverage, not measured effect.

Immune 7 papers · 70%
Gut 5 papers · 50%
Respiratory 4 papers · 40%

Symptoms in the research

Share of this strain's 3 symptom-tagged papers that mention each symptom or condition. Research coverage, not evidence of benefit.

Respiratory infections 3 papers · 100%

Research

10 papers reference this strain in the probiotic database.

Match confidence
2019 IN_VITRO
Probiotic survival during a multi‐layered tablet development as tested in a dynamic, computer‐controlled in vitro model of the stomach and small intestine (TIM‐1)
· Letters in Applied Microbiology
 2016 REVIEW
Oral probiotics as stimulators of anti-infective immune responses in the respiratory tract
Пероральные пробиотики как стимуляторы противоинфекционного иммунного ответа в респираторном тракте
· Terapevticheskii arkhiv
 2016 REVIEW
Oral probiotics as anti-infectious immune response stimulators in the respiratory tract
· Terapevticheskii arkhiv
 2014 OBSERVATIONAL
BION 3 IN PREVENTION OF POSTOPERATIVE COMPLICATIONS AND CORRECTION OF IMMUNE SYSTEM AND GUT MICROBIOTA DISORDERS IN PATIENTS WITH COLORECTAL CANCER
· CyberLeninK (CyberLeninka)
 2012 REVIEW
Scientific Opinion on the substantiation of health claims related to a combination of Lactobacillus gasseri PA 16/8, Bifidobacterium bifidum M 20/5 and Bifidobacterium longum SP 07/3 and maintenance of upper respiratory tract defence against pathogens (ID 931, further assessment) pursuant to Article 13(1) of Regulation (EC) No 1924/2006
· EFSA Journal
 2011 IN_VITRO
Comparative effects of six probiotic strains on immune function in vitro
· British Journal Of Nutrition
 2013 IN_VITRO
Probiotic modulation of dendritic cell function is influenced by ageing
· Immunobiology
 2012 IN_VITRO
Evidence of immunomodulatory effects of a novel probiotic, Bifidobacterium longum bv. infantis CCUG 52486
· FEMS Immunology & Medical Microbiology
 2010 IN_VITRO
Pengaruh Pemberian Glukosa pada Fyltrat Bakteri Probiotik terhadap Pertumbuhan Salmonela typhi Secara In-Vitro
·
2005 RCT
Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: A double blind, randomized, controlled trial
· Clinical Nutrition
Browse all 10 papers →

Discussion

Be the first to comment.

Sign in to join the discussion.

No comments yet.

Citations

Selected papers that name this strain.

  1. [1]
    Probiotic survival during a multi‐layered tablet development as tested in a dynamic, computer‐controlled in vitro model of the stomach and small intestine (TIM‐1)
    · Letters in Applied Microbiology · 2019
    PMID 31454425 →
  2. [2]
    Comparative effects of six probiotic strains on immune function in vitro
    · British Journal Of Nutrition · 2011
    PMID 22054064 →